Drugs / Dextran T-500
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT02456961 Background | Jan 2010 → Dec 2014 | keratoconus | Ufa Eye Research Institute | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dextran T-500 | “0.1% riboflavin-5-phosphate and 20% dextran T-500” NCT02456961 ↗ |
| Route | Topical | “applying a riboflavin solution (0.1% riboflavin-5-phosphate and 20% dextran T-500) to the corneal surface” NCT02456961 ↗ |